The Drug-Induced Respiratory Disease Website
Philippe Camus, M.D.
Browse by »
Pneumonitis (ILD), subacute, moderate
No description available.
Last update :
No medias available.
Acute interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer after crizotinib therapy.
Oxford medical case reports 2014 Apr;2014;11-2 2014 Apr
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
The New England journal of medicine 2010 Oct 28;363;1693-703 2010 Oct 28
Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease: A Retrospective Observational Cohort Study with a Systematic Literature Review.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Aug;10;1148-55 2015 Aug
Crizotinib for the treatment of non-small-cell lung cancer.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2013 Jun 01;70;943-7 2013 Jun 01
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
The New England journal of medicine 2013 Jun 20;368;2385-94 2013 Jun 20
Crizotinib-induced acute interstitial lung disease in a patient with EML4-ALK positive non-small cell lung cancer and chronic interstitial pneumonia.
Acta oncologica (Stockholm, Sweden) 2014 Jan;53;158-60 2014 Jan
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond.
Drug design, development and therapy 2011;5;471-85 2011
Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non-Small Cell Lung Cancer: Independent Review of Four PROFILE Trials.
Clinical lung cancer 2017 Mar 14;; 2017 Mar 14
Managing treatment-related adverse events associated with Alk inhibitors.
Current oncology (Toronto, Ont.) 2014 Feb;21;19-26 2014 Feb
Successful crizotinib rechallenge after crizotinib-induced interstitial lung disease in patients with advanced non-small-cell lung cancer.
Clinical lung cancer 2014 May;15;e33-5 2014 May
Targeted therapy for non-small cell lung cancer.
American journal of respiratory and critical care medicine 2013 Oct 15;188;907-12 2013 Oct 15